ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1490	National Cancer Institute	Html	en	Hypopharyngeal Cancer Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of hypopharyngeal cancer.	statistically significant survival 0.552817 pharynx cancer incidence 0.54678 hypopharyngeal SCCs 0.568302 United States 0.594562 Multiple primary tumors 0.590618 hypopharyngeal wall tumors 0.623965 neck squamous cell 0.598149 PUBMED Abstract 0.631322 pharyngeal cancer 0.54424 5-year disease-free survival 0.561931 Otolaryngol Head Neck 0.607335 squamous cell 0.712263 hypopharyngeal carcinomas 0.629276 neck cancer patients 0.603767 Cancer Res 0.688393 squamous cell cancer 0.573486 hypopharyngeal tumor 0.566864 Abstract 0.707746 pyriform sinus 0.633965 functional larynx 0.541602 patients 0.659221 Hypopharyngeal carcinoma 0.566532 induction chemotherapy arm 0.707576 hypopharyngeal squamous cell 0.623336	squamous cell carcinomas 0.681165 hypopharyngeal SCC 0.56973 upper alimentary tract 0.554127 Natl Cancer Inst 0.619483 pyriform sinus cancer 0.551602 immediate surgery arm 0.623979 neoadjuvant chemotherapy 0.990124 field cancerization 0.600816 hypopharyngeal cancer. 0.653244 significant survival advantage 0.54752 neck cancer 0.685166 Clin Cancer Res 0.614389 radiation therapy 0.868288 Head Neck Surg 0.701435 hypopharyngeal cancers 0.604268 squamous carcinoma 0.542607 induction chemotherapy 0.745083 posterior pharyngeal wall 0.598262 hypopharyngeal cancer 0.866148 prospective randomized trial 0.63031 retrospective study 0.58561 squamous cell carcinoma 0.669554 standard adjuvant therapy 0.638264	CLICK HERE
1653	National Cancer Institute	Html	en	Cancer Genetics Overview (PDQ®)–Health Professional Version	Expert-reviewed information summary in which the features of hereditary cancer and the structure and content of other PDQ cancer genetics summaries are described. The summary also contains an extensive list of genetics resources available online.	risk assessment 0.737084 germline genetic testing 0.616915 pathogenic germline variants 0.607786 genetics cancer risk 0.586595 germline testing 0.54014 individual PDQ summaries 0.545357 common genetic variants 0.594544 Founder pathogenic variants 0.555775 Cancer Genetics Risk 0.634713 tumor sequencing 0.540563 cancer risk counseling 0.587676 genetic risk 0.584149 health care providers 0.553143 genetic risk assessment 0.574763 family members 0.586643 pathogenic variant 0.712171 cancer predisposition genes 0.581734 cancer risk assessment 0.656292 BRCA1/BRCA2 pathogenic variants 0.580746 rare genetic variants 0.585466 familial cancer risk 0.606217 germline pathogenic variant 0.590911 specific pathogenic variant 0.581389 genetic cancer susceptibility 0.617626 genetic sequence testing 0.55336	breast cancer panel 0.575181 genetic counseling 0.75599 certain pathogenic variants 0.569596 cancer susceptibility genes 0.662603 multigene testing 0.554102 pathogenic variants 0.772898 term pathogenic variant 0.577821 genetic information 0.615701 predisposition genetic testing 0.569525 health care 0.629277 actionable genetic variants 0.56222 cancer susceptibility 0.729483 multigene tests 0.585492 Cancer genetic counseling 0.65952 breast cancer 0.623534 cancer predisposition multigene 0.547293 cancer susceptibility gene 0.552935 well-characterized cancer susceptibility 0.539905 genetic variants 0.628939 prostate cancer 0.563348 genetic testing 0.723596 family history 0.559221 cancer risk 0.746235 cancer 0.908258	CLICK HERE
1670	National Cancer Institute	Html	en	Oral Cavity and Oropharyngeal Cancer Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for oral cancer.	cancer treatment 0.462069 cancer screening methods 0.510918 ongoing clinical trials 0.459171 following PDQ summaries 0.498704 PDQ cancer information 0.601619 squamous cells 0.461192 Oropharyngeal cancer forms 0.542461 clinical trials 0.552349 test result 0.478895 cancer information summary 0.545028 clinical trial 0.464502 breast cancer prevention 0.475292 fluorescent mouth rinse 0.459409 PDQ Oral Cavity 0.538179 cancer patients 0.455495 latest published information 0.461223 Oropharyngeal Cancer Prevention 0.539186 NCI’s PDQ 0.469112 cancer symptoms 0.470328 NCI PDQ cancer 0.519444 tests 0.472016 certain types 0.45905 Oral cavity cancer 0.562303 PDQ Screening 0.487794	treatment 0.479473 abnormal tissue 0.496498 screening tests 0.460194 oropharyngeal cancers 0.542436 Cancer Information Service 0.4864 Prevention Editorial Board 0.494212 treatment clinical trials 0.460544 National Cancer Institute 0.552754 PDQ documents 0.4638 new treatment 0.461424 Cancer screening trials 0.51442 oropharyngeal cancer screening 0.581362 Cancer Care page 0.477739 PDQ database 0.466412 PDQ summary 0.507494 cells 0.483262 abnormal red patch 0.460863 abnormal white patch 0.460254 cancer information summaries 0.491365 oral cavity 0.970425 comprehensive cancer information 0.49122 cancer 0.792804 oropharyngeal cancer 0.758721 early stage 0.462272	CLICK HERE
1694	National Cancer Institute	Html	en	Childhood Central Nervous System Germ Cell Tumors Treatment (PDQ®)–Patient Version	Childhood central nervous system (CNS) germ cell tumors form from germ cells (a type of cell that forms as a fetus develops and later becomes sperm in the testicles or eggs in the ovaries). Learn about the signs, tests to diagnose, and treatment of pediatric germ cell tumors in the brain in this expert-reviewed summary.	tumor marker levels 0.3628 cancer treatment 0.421684 Cell Tumors Treatment 0.421872 tumor marker 0.418943 blood tumor marker 0.368072 tumor marker tests 0.401497 germ cell tumor 0.574325 chemotherapy 0.377281 following PDQ summaries 0.365055 PDQ cancer information 0.426073 clinical trials 0.64034 Pediatric Treatment Editorial 0.365107 cancer information summary 0.398144 clinical trial 0.507274 childhood cns 0.519486 tumor markers 0.382879 CNS germ cell 0.581589 Extracranial Germ Cell 0.410121 different types 0.371541 NCI PDQ cancer 0.369493 radiation therapy 0.586685 Treatment Editorial Board 0.36802 Cord Tumors Treatment 0.393052 late effects 0.370411 treatment 0.581174	cancer cells 0.438925 treatment clinical trial 0.368062 PDQ Pediatric Treatment 0.363419 nervous system germ 0.412082 treatment clinical trials 0.389618 National Cancer Institute 0.397655 diagnose childhood CNS 0.382168 spinal cord 0.499499 tumor cells 0.386305 Germ cells tumors 0.441556 new treatment 0.423148 high tumor marker 0.363373 childhood cancer information 0.366666 external radiation therapy 0.366121 brain 0.390174 PDQ summary 0.396735 germ cell tumors 0.941151 cells 0.445231 cancer clinical trials 0.367524 stem cell rescue 0.36994 cancer 0.582086 standard treatment 0.367712 tumor marker level 0.399336 spinal cord tumors 0.390737	CLICK HERE
1908	National Cancer Institute	Html	es	Tratamiento de la leucemia mieloide aguda en adultos (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de la leucemia mieloide aguda en adultos.	linfocítica aguda 0.505572 leucemia promielocítica aguda 0.536157 siguientes procedimientos 0.505247 células madre 0.703397 leucemia mielógena aguda 0.512482 posibles factores 0.501447 siguientes aspectos 0.5019 leucemia aguda 0.511873 radiación quizás 0.505162 leucemia linfoblástica aguda 0.535526 LMA quizás 0.505703 hueso compacto 0.505434 neoplasias mieloides 0.501631 rayos x 0.501258 enlace drugs approved 0.505977 Acute Myeloid Leukemia 0.506164 célula madre mieloide 0.516071 cáncer.ampliar aspiración 0.501565 líquido cefalorraquídeo 0.511938	punción espinal.Ampliar 0.501523 National Cancer Institute 0.501258 leucemia granulocítica aguda 0.512402 Instituto Nacional 0.502137 célula madre linfoide 0.510737 PDQ Tratamiento 0.503456 sustancia química benceno 0.502803 leucemia mielógena 0.513696 médula espinal.ampliar quimioterapia 0.50588 leucemia mieloblástica aguda 0.512403 sistema nervioso central 0.50789 Physician Data Query 0.504454 madre mieloides 0.518606 siguientes situaciones 0.504197 células madre mieloides 0.508803 leucemia mieloide aguda 0.995372 célula madre 0.532153 blastocito mieloide 0.505386 siguientes sumarios 0.503116	CLICK HERE
2987	National Cancer Institute	Html	en	Secondhand Smoke	When you smoke, it doesn't just affect you. And it's not just irritating to those around you, it's deadly.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
15609	National Cancer Institute	Html	es	Tratamiento de los tumores vasculares infantiles (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores vasculares infantiles.	problemas pasajeros 0.409161 lesiones benignas 0.409862 piel vecina 0.430821 efectos secundarios meses 0.423036 importantes preguntas 0.409508 siguientes especialistas 0.418218 siguientes síndromes 0.413185 rayos x 0.412063 niño ayuda 0.413721 escamas llamadas placas 0.409897 tumores benignos 0.516528 tumor vascular benigno 0.534618 Instituto Nacional 0.412348 alta potencia 0.411312 células llamadas 0.410367 tumores vasculares benignos 0.9178 venas sanas vecinas 0.421159 nuevos tipos 0.412108 sangre circula 0.414383 medicamentos propranolol hydrochloride 0.437459 angiofibroma nasofaríngeo 0.468048 hemangioendotelioma epitelioides 0.436434 once tipos 0.436191 glándula tiroides 0.427118 posibles efectos tardíos 0.424225	adultos jóvenes 0.418525 siguientes tumores 0.604051 granulomas piógenos 0.445724 hemangioma capilar lobulillar 0.505924 siguientes tipos 0.41901 ondas sonoras 0.412577 efectos tardíos 0.50862 PDQ Efectos tardíos 0.43716 vías respiratorias 0.428225 tarde.ampliar ecografía 0.413763 granuloma piógeno 0.509033 IRMN).Ampliar Imágenes 0.410245 sección opciones 0.41178 hemangioendoteliomas epitelioides 0.418326 PDQ Tratamiento 0.421361 afección llamada esclerosis 0.414532 siguientes signos 0.417619 siguientes casos 0.414811 Physician Data Query 0.425443 propranolol iv 0.42341 insuficiencia cardíaca 0.475544 hemangioma epitelioide 0.568564 siguientes pruebas 0.434586 angiofibromas nasofaríngeos juveniles 0.440153	CLICK HERE
16681	National Cancer Institute	Html	en	Cancer Moonshot℠ Blue Ribbon Panel Members	Information about the Cancer Moonshot Blue Ribbon Panel of experts. The panel was established to ensure the Cancer Moonshot's goals and approaches are grounded in the best science.	Walton Endowed Chair 0.567818 Cancer Genome Computational 0.597352 National Cancer Advisory 0.650925 cancer advocacy groups 0.631303 Integrative Cancer Research 0.659981 Cancer Disparities Program 0.610947 C. Zamecnik Chair 0.57469 Senior Vice President 0.528963 Harvard Medical School 0.539573 Chief Executive Officer 0.838453 Moores Cancer Center 0.633784 Cancer Center 0.989395 Principal Deputy Director 0.559096 Kimmel Cancer Center 0.636717 MGH Cancer Center 0.643509 Associate Professor 0.561481 Texas MD Anderson 0.619653 Scott Cancer Center 0.628322 Hopkins University School 0.586476 Lurie Comprehensive Cancer 0.604578 National Brain Tumor 0.535602 Alumni Distinguished Professor 0.55884 cancer health disparities 0.665713 Thomas Jefferson University 0.541957 cancer prevention 0.57231	Lineberger Comprehensive Cancer 0.60209 Huntsman Cancer Institute 0.643082 Ph.D 0.602332 Anderson Cancer Center 0.720144 Dana-Farber Cancer Institute 0.630726 Louisiana State University 0.545794 Pfizer Worldwide Research 0.555824 National Cancer Institute 0.714187 Cancer Research 0.712054 Sidney Kimmel 0.530896 Hospital Cancer Center 0.648303 Blue Ribbon Panel 0.726957 M.D 0.540388 Executive Vice President 0.545293 MD Anderson Cancer 0.692003 Ludwig Cancer Research 0.634757 Clinical Cancer Care 0.584227 Comprehensive Cancer Center 0.832766 Clausen Distinguished Professor 0.578861 Cancer Survivorship 0.543835 Kimmel Comprehensive Cancer 0.643464 Vanderbilt-Ingram Cancer Center 0.63051 University Feinberg School 0.566744 Deputy Director 0.630447	CLICK HERE
16775	National Cancer Institute	Html	es	Cancell/Cantron/Protocel (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos sobre el uso de Cancell/Entelev como tratamiento para personas con cáncer. Nota: La información contenida en este sumario ya no se actualiza y se ofrece solo con fines de consulta.	Centro Nacional 0.429084 New Hampshire Avenue 0.419912 cabo ensayos 0.419001 Drug Administration 0.412413 NCI Best Case 0.439351 tipo cancell 0.440349 mejores pruebas 0.415762 datos bibliográficos pubmed 0.42161 siguientes preguntas 0.412513 James V 0.418429 National Cancer Institute 0.425345 siguientes riesgos 0.416342 seguro médico 0.411884 Instituto Nacional 0.685274 vitamina e 0.418575 Salud Complementaria 0.444832	Visuals Online 0.415001 complementarias revisa 0.421711 Physician Data Query 0.488672 nombre cancell 0.440323 Estados Unidos 0.994944 libre uso 0.416016 suficiente actividad 0.418205 siguientes sustancias 0.422749 página manejo 0.413947 ¿El tratamiento 0.424367 ¿Los beneficios 0.412704 juntos cam 0.411781 Series Program 0.412549 medicina complementaria 0.882014 Institutos Nacionales 0.47694	CLICK HERE
16841	National Cancer Institute	Html	en	Nanotechnology Characterization Laboratory (NCL)	The Nanotechnology Characterization Laboratory (NCL) is accelerating the development of promising nanotechnology therapies and diagnostics.	extensive educational outreach 0.634447 FDA 0.244496 Nanotechnology Characterization Laboratory 0.767048 oncology-directed therapies 0.46705 great strides 0.507003 pursuit 0.246467 death rate 0.462099 Drug Administration 0.456372 unique setup 0.432854 progression 0.249487 concert 0.241265 effort 0.242009 extraordinary opportunity 0.441323 dozen NCL collaborators 0.920466 disadvantages 0.25207 relatively limited time 0.630205 biocompatibility trends 0.467853 National Cancer Institute 0.664151 National Institute 0.449153 Food 0.241207	human clinical trials 0.632541 development 0.239992 clinical translation 0.459921 therapeutic outcomes 0.469235 diagnosis 0.245742 difficult diseases 0.491415 diagnostic capabilities 0.458058 novel nanomedicines 0.45591 vast array 0.436858 different nanomaterials 0.457741 Standards 0.240975 population 0.239972 diagnostics 0.244317 advantages 0.242363 cancers 0.321573 foremost nanotechnology research 0.719052 preclinical characterization 0.513184 novel treatment strategies 0.62837 incidence 0.254427 multi-disciplinary team 0.450189	CLICK HERE